MedTrace Logo

Prospective Observational Cohort Study

NCT06493448 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1326

Last updated 2024-07-10

No results posted yet for this study

Summary

The goal of this observational study is to learn about the overall disease status, diagnostic and therapeutic modalities, and prognosis of patients with gastric cancer liver metastasis(GCLM) in China. The investigators divided the participants into three groups( three types) of gastric cancer liver metastasis based onChinese c-GCLM classification system.The main question it aims to answer is:

1. How long do patients with GCLM live?
2. How different treatment modalities (surgery, chemotherapy, immunotherapy, targeted therapy and others) affect patients' prognosis of three type? All participants will be tracked for their physical condition.

Conditions

Interventions

OTHER

observation

This is an observational study.

Sponsors & Collaborators

  • Peking University International Hospital

    collaborator OTHER

  • Chinese PLA General Hospital

    collaborator OTHER

  • Lin Chen

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-15
Primary Completion
2026-07-30
Completion
2028-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06493448 on ClinicalTrials.gov